Literature DB >> 22885617

Influence of surgeon's experience on fluoroscopy time during endourological interventions.

M Ritter1, F Siegel, P Krombach, A Martinschek, C Weiss, A Häcker, A E Pelzer.   

Abstract

INTRODUCTION AND
OBJECTIVE: Fluoroscopy time influences radiation exposure of both surgeons and patients during endourological interventions. Changes in fluoroscopy habits of endourological surgeons after being informed about their fluoroscopy times were evaluated depending on their endourological experience.
MATERIALS AND METHODS: From April 2010 to April 2011, 402 endourological interventions in 337 Patients were assessed. Evaluated interventions were ureter stent placement (USP), ureter stent change (USC) nephrostomy change (NC), ureterorenoscopy (URS) and percutaneous nephrolithotomy (PCNL). Fluoroscopy time (FT) and operation time (OT) were recorded. For USP, USC and NC, the surgeons were divided into two groups: group I with >2 years of endourological experience and group II with <2 years experience. URS and PCNL only were performed by experienced surgeons. After 6 months, all surgeons were informed about their mean detected results. Both groups were compared, and changes in FT and OT in the second part of the study were analysed.
RESULTS: Surgeons reduced their median fluoroscopy times up to 55 % after being informed about their fluoroscopy manners. Experienced surgeons reduced both operation and fluoroscopy times significantly for USP, USC and NC. For URS and PCNL, and OT and FT, the differences were not statistically significant. Inexperienced surgeons were not able to reduce both OT and FT significantly.
CONCLUSION: If experienced surgeons are informed about their fluoroscopy time during endourological interventions, fluoroscopy times can be reduced significantly in easy procedures, which leads to less radiation exposure of surgeons and patients. Inexperienced surgeons have less possibility to influence their fluoroscopy manners.

Entities:  

Mesh:

Year:  2012        PMID: 22885617     DOI: 10.1007/s00345-012-0923-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  15 in total

1.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

2.  Physician documentation of fluoroscopy time in voiding cystourethrography reports correlates with lower fluoroscopy times: a surrogate marker of patient radiation exposure.

Authors:  Stephen Darling; Marla Sammer; Teresa Chapman; Marguerite T Parisi
Journal:  AJR Am J Roentgenol       Date:  2011-06       Impact factor: 3.959

3.  Determination of patient radiation dose during ureteroscopic treatment of urolithiasis using a validated model.

Authors:  Michael E Lipkin; Agnes J Wang; Greta Toncheva; Michael N Ferrandino; Terry T Yoshizumi; Glenn M Preminger
Journal:  J Urol       Date:  2012-01-20       Impact factor: 7.450

4.  Fluoroscopic organ and tissue-specific radiation exposure by sex and body mass index during ureteroscopy.

Authors:  Nathaniel Krupp; Ryan Bowman; Christopher Tenggardjaja; Forrest Jellison; Bryan Hill; Kamyar Ebrahimi; Jason Smith; Donald Farley; D Duane Baldwin
Journal:  J Endourol       Date:  2010-07       Impact factor: 2.942

5.  Monitoring radiation exposure to medical personnel during percutaneous nephrolithotomy.

Authors:  F C Lowe; M Auster; T J Beck; R Chang; F F Marshall
Journal:  Urology       Date:  1986-09       Impact factor: 2.649

6.  Factors affecting patient radiation exposure during percutaneous nephrolithotomy.

Authors:  John G Mancini; Eliza M Raymundo; Michael Lipkin; Dorit Zilberman; Daniel Yong; Lionel L Bañez; Michael J Miller; Glenn M Preminger; Michael N Ferrandino
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

7.  Radiation exposure to the patient and operating room personnel during percutaneous nephrolithotomy.

Authors:  Geeta Kumari; Pratik Kumar; Pankaj Wadhwa; Monish Aron; Narmada P Gupta; Prem N Dogra
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

8.  Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers.

Authors:  Michael N Ferrandino; Aditya Bagrodia; Sean A Pierre; Charles D Scales; Edward Rampersaud; Margaret S Pearle; Glenn M Preminger
Journal:  J Urol       Date:  2008-12-18       Impact factor: 7.450

9.  Radiation doses in interventional radiology procedures: the RAD-IR study: part I: overall measures of dose.

Authors:  Donald L Miller; Stephen Balter; Patricia E Cole; Hollington T Lu; Beth A Schueler; Michael Geisinger; Alejandro Berenstein; Robin Albert; Jeffrey D Georgia; Patrick T Noonan; John F Cardella; James St George; Eric J Russell; Tim W Malisch; Robert L Vogelzang; George L Miller; Jon Anderson
Journal:  J Vasc Interv Radiol       Date:  2003-06       Impact factor: 3.464

10.  Radiation exposure from fluoroscopy during fixation of hip fracture and fracture of ankle: Effect of surgical experience.

Authors:  Rajesh Botchu; Kassetti Ravikumar
Journal:  Indian J Orthop       Date:  2008-10       Impact factor: 1.251

View more
  9 in total

1.  New developed urological protocols for the Uro Dyna-CT reduce radiation exposure of endourological patients below the levels of the low dose standard CT scans.

Authors:  M-C Rassweiler; R Banckwitz; C Koehler; B Mueller-Allissat; M-S Michel; A Häcker; M Ritter
Journal:  World J Urol       Date:  2013-10-30       Impact factor: 4.226

2.  Assessment of percutaneous renal access skills during Urology Objective Structured Clinical Examinations (OSCE).

Authors:  Yasser A Noureldin; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

3.  Fluoroscopy time during uncomplicated unilateral ureteroscopy for urolithiasis decreases with urology resident experience.

Authors:  Lancaster R Weld; Uzoamaka O Nwoye; Richard B Knight; Timothy S Baumgartner; James S Ebertowski; Matthew T Stringer; Matthew C Kasprenski; Kyle J Weld
Journal:  World J Urol       Date:  2014-02-23       Impact factor: 4.226

4.  Mobile augmented reality for computer-assisted percutaneous nephrolithotomy.

Authors:  Michael Müller; Marie-Claire Rassweiler; Jan Klein; Alexander Seitel; Matthias Gondan; Matthias Baumhauer; Dogu Teber; Jens J Rassweiler; Hans-Peter Meinzer; Lena Maier-Hein
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-03-23       Impact factor: 2.924

5.  Assessing radiation exposure during endoscopic-guided percutaneous nephrolithotomy.

Authors:  Andrea G Lantz; Padraic O'Malley; Michael Ordon; Jason Y Lee
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

6.  Extracorporeal shock waves lithotripsy versus retrograde ureteroscopy: is radiation exposure a criterion when we choose which modern treatment to apply for ureteric stones?

Authors:  Catalin Pricop; Adrian Maier; Dragos Negru; Ovidiu Malau; Martha Orsolya; Daniel Radavoi; Dragomir R Serban
Journal:  Bosn J Basic Med Sci       Date:  2014-10-18       Impact factor: 3.363

Review 7.  Lifetime Radiation Exposure in Patients with Recurrent Nephrolithiasis.

Authors:  Mohamed A Elkoushy; Sero Andonian
Journal:  Curr Urol Rep       Date:  2017-09-12       Impact factor: 3.092

8.  Stepwise case selection using Guy's stone score reduces complications during percutaneous nephrolithotomy training.

Authors:  Jiten Jaipuria; Manav Suryavanshi; Amitsinh P Desai; Sanjay Goyal; Kaushal Patel; Sandip S Parhad; Santosh K Subudhi; Chandrashekar V Rao; Satish P Kumar; Tridib K Sen
Journal:  Indian J Urol       Date:  2017 Jan-Mar

9.  Radiation exposure during retrograde intrarenal surgery (RIRS): a prospective multicenter evaluation.

Authors:  Simon Hein; Konrad Wilhelm; Arkadiusz Miernik; Martin Schoenthaler; Rodrigo Suarez-Ibarrola; Christian Gratzke; Johannes Salem; Leonidas Karapanos; Christopher Netsch; Benedikt Becker; Armin Secker; Julian Veser; Andreas Neisius; Hans-Martin Fritsche; Marco Julius Schnabel
Journal:  World J Urol       Date:  2020-03-21       Impact factor: 4.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.